Your browser doesn't support javascript.
loading
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Perl, Alexander E; Hosono, Naoko; Montesinos, Pau; Podoltsev, Nikolai; Martinelli, Giovanni; Panoskaltsis, Nicki; Recher, Christian; Smith, Catherine C; Levis, Mark J; Strickland, Stephen; Röllig, Christoph; Groß-Langenhoff, Marco; Chou, Wen-Chien; Lee, Je-Hwan; Yokoyama, Hisayuki; Hasabou, Nahla; Lu, Qiaoyang; Tiu, Ramon V; Altman, Jessica K.
Afiliação
  • Perl AE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. alexander.perl@pennmedicine.upenn.edu.
  • Hosono N; University of Fukui, Fukui, Japan.
  • Montesinos P; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Podoltsev N; Yale School of Medicine, New Haven, CT, USA.
  • Martinelli G; Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST S. r. l, Meldola, Italy.
  • Panoskaltsis N; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
  • Recher C; Cancer Research Center of Toulouse, Toulouse, France.
  • Smith CC; University of California-San Francisco, San Francisco, CA, USA.
  • Levis MJ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Strickland S; Vanderbilt Ingram Cancer Center, Nashville, TN, USA.
  • Röllig C; Universitätsklinikum Carl Gustav Carus, Dresden, Germany.
  • Groß-Langenhoff M; Astellas Pharma GmbH, Munich, Germany.
  • Chou WC; National Taiwan University Hospital, Taipei, Taiwan.
  • Lee JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Yokoyama H; Sendai Medical Center, National Hospital Organization, Sendai, Japan.
  • Hasabou N; Tohoku University, National Hospital Organization, Sendai, Japan.
  • Lu Q; Astellas Pharma US, Northbrook, IL, USA.
  • Tiu RV; Astellas Pharma US, Northbrook, IL, USA.
  • Altman JK; Astellas Pharma US, Northbrook, IL, USA.
Blood Cancer J ; 12(5): 84, 2022 05 30.
Article em En | MEDLINE | ID: mdl-35637252
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos